New blood thinner may beat aspirin for aneurysm patients
NCT ID NCT07089862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a drug called indobufen works better than aspirin at preventing strokes and blood clots after a brain aneurysm is fixed with a stent or coil. About 2,500 people with unruptured brain aneurysms will take either indobufen or aspirin, plus clopidogrel, for 6 months after their procedure. Researchers will track strokes, bleeding, and other complications to see which regimen is safer and more effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOBUFEN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Capital Medical University Affiliated Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which brain aneurysm treatment is safer? a Head-to-Head test
- Can 4D-MRI spot brain aneurysms before they rupture?
- Which anesthesia is safer for brain aneurysm repair? new study investigates
- Brain aneurysm study aims to predict rupture risk without surgery
- Massive study reveals best approaches for silent brain aneurysms
- Ear zap may stop Post-Surgery headaches in aneurysm patients